Mary Ann Gray
Director, Acadia Pharmaceuticals.
Companies
- Compass Therapeutics, Inc.Board member Apr 28, 2022 to now1
- Keros Therapeutics, Inc.Board member Dec 21, 2020 to now2
- BioAtlaBoard member Dec 15, 2020 to now3
- RAPT Therapeutics, Inc.Board member Dec 6, 2019 to now4
- PALISADE BIO, INC.Board member Oct 11, 2019 to Nov 24, 20235
- Sarepta TherapeuticsBoard member Dec 11, 2018 to Mar 8, 20226
- SenomyxBoard member Sep 28, 2010 to Nov 2, 20187
- Galena BiopharmaBoard member Apr 28, 2016 to Oct 10, 20178
- Acadia PharmaceuticalsBoard member Jun 15, 2006 to Jun 9, 20169
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sarepta Therapeutics SRPT12,356 shares10$218.9K at $17.71Mar 7, 2022- Keros Therapeutics, Inc. KROS12,392 shares11$136.8K at $11.04Jun 3, 2026
- BioAtla BCAB77,397 shares12$94.4K at $1.22Jun 18, 2025
- RAPT Therapeutics, Inc.0 shares13Mar 3, 2026
- Compass Therapeutics, Inc. CMPX0 shares14Apr 28, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Granted 7,142 shares of Keros Therapeutics, Inc.11
- Mar 3, 2026U 4,956 shares of RAPT Therapeutics, Inc.13
- Jan 30, 2026Granted 4,956 shares of RAPT Therapeutics, Inc.15
- Jun 18, 2025Granted 23,500 shares of BioAtla12
- Jun 4, 2025Granted 5,250 shares of Keros Therapeutics, Inc.16
- Jun 13, 2024Granted 16,500 shares of BioAtla17
- Dec 31, 2023Granted 5,995 shares of BioAtla18
- Sep 30, 2023Granted 8,676 shares of BioAtla19
- Jun 30, 2023Granted 4,916 shares of BioAtla20
- Mar 31, 2023Granted 5,503 shares of BioAtla21
- Mar 7, 2022Granted 2,953 shares of Sarepta Therapeutics10
- Dec 10, 2021Exercised options 967 shares of Sarepta Therapeutics22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARBioAtla, Board member
- 4
- 5SEC EDGARPALISADE BIO, INC., Board member
- 6SEC EDGARSarepta Therapeutics, Board member
- 7SEC EDGARSenomyx, Board member
- 8SEC EDGARGalena Biopharma, Board member
- 9SEC EDGARAcadia Pharmaceuticals, Board member
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Feb 2, 2026
- 16SEC EDGARForm 4 filed Jun 6, 2025
- 17SEC EDGARForm 4 filed Jun 14, 2024
- 18SEC EDGARForm 4 filed Jan 3, 2024
- 19SEC EDGARForm 4 filed Oct 3, 2023
- 20SEC EDGARForm 4 filed Jul 5, 2023
- 21SEC EDGARForm 4 filed May 15, 2023
- 22SEC EDGARForm 4 filed Dec 14, 2021